Hypoxia and nickel inhibit histone demethylase JMJD1A and repress Spry2 expression in human bronchial epithelial BEAS-2B cells
Open Access
- 29 September 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 31 (12), 2136-2144
- https://doi.org/10.1093/carcin/bgq197
Abstract
Epigenetic silencing of tumor suppressor genes commonly occurs in human cancers via increasing DNA methylation and repressive histone modifications at gene promoters. However, little is known about how pathogenic environmental factors contribute to cancer development by affecting epigenetic regulatory mechanisms. Previously, we reported that both hypoxia and nickel (an environmental carcinogen) increased global histone H3 lysine 9 methylation in cells through inhibiting a novel class of iron- and α-ketoglutarate-dependent histone demethylases. Here, we investigated whether inhibition of histone demethylase JMJD1A by hypoxia and nickel could lead to repression/silencing of JMJD1A-targeted gene(s). By using Affymetrix GeneChip and ChIP-on-chip technologies, we identified Spry2 gene, a key regulator of receptor tyrosine kinase/extracellular signal-regulated kinase (ERK) signaling, as one of the JMJD1A-targeted genes in human bronchial epithelial BEAS-2B cells. Both hypoxia and nickel exposure increased the level of H3K9me2 at the Spry2 promoter by inhibiting JMJD1A, which probably led to a decreased expression of Spry2 in BEAS-2B cells. Repression of Spry2 potentiated the nickel-induced ERK phosphorylation, and forced expression of Spry2 in BEAS-2B cells decreased the nickel-induced ERK phosphorylation and significantly suppressed nickel-induced anchorage-independent growth. Taken together, our results suggest that histone demethylases could be targets of environmental carcinogens and their inhibition may lead to altered gene expression and eventually carcinogenesis.Keywords
This publication has 55 references indexed in Scilit:
- Epigenetic inactivation of the ERK inhibitor Spry2 in B-cell diffuse lymphomasOncogene, 2008
- Hypoxia induces an autocrine‐paracrine survival pathway via platelet‐derived growth factor (PDGF)‐B/PDGF‐β receptor/phosphatidylinositol 3‐kinase/Akt signaling in RN46A neuronal cellsThe FASEB Journal, 2003
- Analysis of specific lysine histone H3 and H4 acetylation and methylation status in clones of cells with a gene silenced by nickel exposureToxicology and Applied Pharmacology, 2003
- Sprouty Fine-Tunes EGF Signaling through Interlinked Positive and Negative Feedback LoopsCurrent Biology, 2003
- Role of MAP kinase in tumor progression and invasionCancer and Metastasis Reviews, 2003
- Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signallingThe EMBO Journal, 2002
- The bimodal regulation of epidermal growth factor signaling by human Sprouty proteinsProceedings of the National Academy of Sciences of the United States of America, 2002
- Reactive Oxygen-induced Carcinogenesis Causes Hypermethylation of p16Ink4a and Activation of MAP KinaseMolecular Medicine, 2002
- The histone deacetylase inhibitor trichostatin A reduces nickel-induced gene silencing in yeast and mammalian cellsMutation Research, 2001
- Mammalian Sprouty-1 and -2 Are Membrane-Anchored Phosphoprotein Inhibitors of Growth Factor Signaling in Endothelial CellsThe Journal of cell biology, 2001